Renasant Bio
PrivateLast Round
Seed
Jul 10, 2025
Total Funding Raised
$54.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Renasant Bio operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Seed round in July 2025.
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to target the underlying biology of autosomal dominant polycystic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renasant Bio Comparables
Compare Renasant Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mironid | 84% | |
| Estuary Biotherapeutics | 82% | |
| Vertex Pharmaceuticals | 74% |
For institutional investors. Book with your work email.
Renasant Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Renasant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| 5AM Ventures | Seed |
| Qiming | Seed |
| Atlas Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 159% MoM.
- Jul 2, 2026
Grew 18% QoQ, from 28 to 33 employees.
For institutional investors. Book with your work email.
Renasant Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renasant Bio's valuation, stock price, and market status.
Is Renasant Bio a public or private company?
Renasant Bio is a private company.
What is the current stock price of Renasant Bio?
Renasant Bio is a private company, so its shares have no public market price. Caplight tracks Renasant Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renasant Bio worth (valuation)?
Valuation information for Renasant Bio is not publicly available.
Can I buy Renasant Bio stock?
Renasant Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renasant Bio's last funding round?
Renasant Bio's most recent funding round was Seed on July 10, 2025.
Who are the main investors in Renasant Bio?
Key investors in Renasant Bio include 5AM Ventures.
Will Renasant Bio IPO soon?
No public IPO plans have been announced for Renasant Bio.
How can I track Renasant Bio secondary market activity?
Caplight tracks bids, offers, and trades in Renasant Bio's shares on secondary markets.